Annual Operating Profit
-$27.15 M
+$48.05 M+63.90%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual operaing income is currently -$27.15 million, with the most recent change of +$48.05 million (+63.90%) on 31 December 2023. ZBIO annual operating profit is now at all-time high.ZBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$40.98 M
-$1.28 M-3.23%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly operating income is currently -$40.98 million, with the most recent change of -$1.28 million (-3.23%) on 30 September 2024. Over the past year, it has dropped by -$76.61 million (-215.05%). ZBIO quarterly operating profit is now -215.05% below its all-time high of $35.62 million, reached on 30 September 2023.ZBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$133.04 M
-$76.61 M-135.75%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM operating income is currently -$133.04 million, with the most recent change of -$76.61 million (-135.75%) on 30 September 2024. Over the past year, it has dropped by -$168.67 million (-473.46%). ZBIO TTM operating profit is now -473.46% below its all-time high of $35.62 million, reached on 30 September 2023.ZBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.9% | -215.1% | -473.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +63.9% | -215.1% | at low | -473.5% | at low |
| 5 y | 5 years | at high | +63.9% | -215.1% | at low | -473.5% | at low |
| alltime | all time | at high | +63.9% | -215.1% | at low | -473.5% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$40.98 M(+3.2%) | -$133.04 M(+135.7%) |
| June 2024 | - | -$39.70 M(+44.0%) | -$56.44 M(+237.3%) |
| Mar 2024 | - | -$27.58 M(+11.3%) | -$16.73 M(-254.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$27.15 M(-63.9%) | -$24.78 M(-169.6%) | $10.85 M(-69.6%) |
| Sept 2023 | - | $35.62 M | $35.62 M |
| Dec 2022 | -$75.20 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual operaing income?
- What is the all time high annual operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual operating profit year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating income?
- What is the all time high quarterly operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating profit year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM operating income?
- What is the all time high TTM operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM operating profit year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual operaing income?
The current annual operating profit of ZBIO is -$27.15 M
What is the all time high annual operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual operaing income is -$27.15 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual operating profit year-on-year change?
Over the past year, ZBIO annual operaing income has changed by +$48.05 M (+63.90%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating income?
The current quarterly operating profit of ZBIO is -$40.98 M
What is the all time high quarterly operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly operating income is $35.62 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating profit year-on-year change?
Over the past year, ZBIO quarterly operating income has changed by -$76.61 M (-215.05%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM operating income?
The current TTM operating profit of ZBIO is -$133.04 M
What is the all time high TTM operating profit for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM operating income is $35.62 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM operating profit year-on-year change?
Over the past year, ZBIO TTM operating income has changed by -$168.67 M (-473.46%)